232.12 4.29 (1.88%)
2.5M XNYS Volume
XNYS 18 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Richard E. Byrd | EVP & President Interventional | Sale of securities on an exchange or to another person at price $ 224.91 per share. | 12 Mar 2025 | 1,940 | 7,411 (0%) | 0% | 224.9 | 436,325 | Common Stock |
| Michael D. Garrison | EVP & President Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2025 | 178 | 5,366 (0%) | 0% | 0 | Common Stock | |
| Bertram L. Scott | Director | Sale of securities on an exchange or to another person at price $ 227.99 per share. | 12 Feb 2025 | 700 | 36,033 (0%) | 0% | 228.0 | 159,593 | Common Stock |
| Jeffrey W. Henderson | Director | Purchase of securities on an exchange or from another person at price $ 233.62 per share. | 10 Feb 2025 | 1,500 | 8,015 (0%) | 0% | 233.6 | 350,430 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 222 | 10,662 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 121 | 1,552 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Bertram L. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 36,733 (0%) | 0% | 0 | Common Stock | |
| Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 14,264 (0%) | 0% | 0 | Common Stock | |
| Claire M. Fraser-Liggett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 24,006 (0%) | 0% | 0 | Common Stock | |
| Timothy M. Ring | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 57,915 (0%) | 0% | 0 | Common Stock | |
| William M. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 3,486 (0%) | 0% | 0 | Common Stock | |
| Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 6,515 (0%) | 0% | 0 | Common Stock | |
| R. Andrew Eckert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 9,170 (0%) | 0% | 0 | Common Stock | |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 22,701 (0%) | 0% | 0 | Common Stock | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 3,834 (0%) | 0% | 0 | Common Stock | |
| Joanne Waldstreicher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 2,270 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Sale of securities on an exchange or to another person at price $ 240.00 per share. | 21 Jan 2025 | 787 | 15,414 (0%) | 0% | 240 | 188,880 | Common Stock |
| David Shan | EVP and Chief ISC Officer | Sale of securities on an exchange or to another person at price $ 240.00 per share. | 21 Jan 2025 | 500 | 5,741 (0%) | 0% | 240 | 120,000 | Common Stock |
| Michael D. Garrison | EVP & President, Medical | Sale of securities on an exchange or to another person at price $ 236.51 per share. | 17 Jan 2025 | 597 | 5,544 (0%) | 0% | 236.5 | 141,196 | Common Stock |
| David Shan | EVP and Chief ISC Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jan 2025 | 44 | 6,241 (0%) | 0% | 0 | Common Stock | |
| Garrison Michael D. | EVP & President, Medical | Sale of securities on an exchange or to another person at price $ 223.33 per share. | 19 Dec 2024 | 2,838 | 6,141 (0%) | 0% | 223.3 | 633,811 | Common Stock |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 6,995 | 0 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2024 | 6,339 | 0 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Sale of securities on an exchange or to another person at price $ 219.03 per share. | 06 Dec 2024 | 638 | 14,217 (0%) | 0% | 219.0 | 139,741 | Common Stock |
| Roland Goette | EVP and President, EMEA | Sale or transfer of securities back to the company at price $ 221.01 per share. | 06 Dec 2024 | 9,490 | 14,855 (0%) | 0% | 221.0 | 2,097,385 | Common Stock |
| Roland Goette | EVP and President, EMEA | Sale of securities on an exchange or to another person at price $ 221.01 per share. | 06 Dec 2024 | 4,483 | 24,345 (0%) | 0% | 221.0 | 990,788 | Common Stock |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 167.91 per share. | 06 Dec 2024 | 6,339 | 28,828 (0%) | 0% | 167.9 | 1,064,381 | Common Stock |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 147.68 per share. | 06 Dec 2024 | 6,995 | 22,489 (0%) | 0% | 147.7 | 1,033,022 | Common Stock |
| Shana Carol Neal | EVP and Chief People Officer | Sale of securities on an exchange or to another person at price $ 220.49 per share. | 06 Dec 2024 | 1,000 | 16,989 (0%) | 0% | 220.5 | 220,490 | Common Stock |
| David Shan | EVP and Chief ISC Officer | Sale of securities on an exchange or to another person at price $ 220.25 per share. | 05 Dec 2024 | 1,500 | 6,285 (0%) | 0% | 220.3 | 330,375 | Common Stock |
| Thomas E. Polen | Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 23,564 | 100,371 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 36,585 | 123,935 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 15,539 | 87,350 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 60,891 | 60,891 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 3,697 | 3,697 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,161 | 15,690 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 944 | 13,529 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 196 | 15,494 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,109 | 18,498 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 509 | 17,989 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 8,264 | 8,264 | - | - | Stock Appreciation Rights | |
| Antoine C. Ezell | EVP, President Americas & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 5,437 | 5,437 | - | - | Stock Appreciation Rights | |
| Antoine C. Ezell | EVP, President Americas & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 1,388 | 10,708 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President Americas & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 1,357 | 11,970 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President Americas & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,619 | 13,327 (0%) | 0% | 0 | Common Stock | |
| Christopher J. DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 5,192 | 21,499 (0%) | 0% | 0 | Common Stock | |
| Christopher J. DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 19,138 | 19,138 | - | - | Stock Appreciation Rights | |
| Christopher J. DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 9,015 | 26,691 (0%) | 0% | 0 | Common Stock | |
| Christopher J. DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 4,884 | 17,676 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,275 | 10,209 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,553 | 7,934 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President, Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 1,230 | 8,979 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President, Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 10,004 | 10,004 | - | - | Stock Appreciation Rights | |
| Richard Byrd | EVP & President Interventional | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,220 | 8,280 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 8,699 | 8,699 | - | - | Stock Appreciation Rights | |
| Richard Byrd | EVP & President Interventional | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 1,204 | 9,351 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,275 | 10,555 (0%) | 0% | 0 | Common Stock | |
| David Shan | EVP and Chief ISC Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 124 | 7,785 (0%) | 0% | 0 | Common Stock | |
| David Shan | EVP and Chief ISC Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 1,110 | 6,803 (0%) | 0% | 0 | Common Stock | |
| David Shan | EVP and Chief ISC Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 1,106 | 7,909 (0%) | 0% | 0 | Common Stock | |
| David Shan | EVP and Chief ISC Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 4,350 | 4,350 | - | - | Stock Appreciation Rights | |
| Michelle Quinn | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 7,568 | 7,568 | - | - | Stock Appreciation Rights | |
| Michelle Quinn | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 376 | 6,927 (0%) | 0% | 0 | Common Stock | |
| Michelle Quinn | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 416 | 7,984 | - | - | Rights to Common Stock Under Deferred Compensation Plan | |
| Michelle Quinn | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 1,932 | 6,887 (0%) | 0% | 0 | Common Stock | |
| Michelle Quinn | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 416 | 7,303 (0%) | 0% | 0 | Common Stock | |
| Michael Feld | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 10,004 | 10,004 | - | - | Stock Appreciated Rights | |
| Michael Feld | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 2,553 | 9,190 (0%) | 0% | 0 | Common Stock | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 3,426 | 3,426 | - | - | Stock Appreciation Rights | |
| Mocherla Pavan Kumar | EVP & President Greater Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 875 | 2,692 (0%) | 0% | 0 | Common Stock | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 20 | 2,852 (0%) | 0% | 0 | Common Stock | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 180 | 2,872 (0%) | 0% | 0 | Common Stock | |
| Pavan Kumar Mocherla | EVP & President, Greater Asia | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2024 | 25 | 2,847 (0%) | 0% | 0 | Common Stock | |
| Michelle Quinn | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 416 | 416 | - | - | Rights to Common Stock Under Deferred Compensation Plan | |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 128 | 10,392 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 128 | 1,424 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Sep 2024 | 466 | 12,792 (0%) | 0% | 0 | Common Stock | |
| Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2024 | 254 | 13,258 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2024 | 216 | 6,060 (0%) | 0% | 0 | Common Stock | |
| Michael Feld | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 6,637 | 6,637 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 5,295 | 0 | - | - | Stock Appreciated Rights | |
| Roland Goette | EVP and President EMEA | Sale or transfer of securities back to the company at price $ 234.08 per share. | 14 Aug 2024 | 4,018 | 12,585 (0%) | 0% | 234.1 | 940,533 | Common Stock |
| Roland Goette | EVP and President EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.54 per share. | 14 Aug 2024 | 5,295 | 16,603 (0%) | 0% | 132.5 | 701,799 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 124 | 10,224 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 124 | 1,291 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Thomas Spoerel | SVPController & Chief Acct Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jul 2024 | 48 | 1,928 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | SVP,Controller&Chief Acct Off | Sale of securities on an exchange or to another person at price $ 239.31 per share. | 10 Jun 2024 | 300 | 1,976 (0%) | 0% | 239.3 | 71,793 | Common Stock |
| Roland Goette | EVP and President EMEA | Sale of securities on an exchange or to another person at price $ 235.29 per share. | 15 May 2024 | 800 | 13,808 (0%) | 0% | 235.3 | 188,232 | Common Stock |
| Roland Goette | EVP and President EMEA | Sale of securities on an exchange or to another person at price $ 237.46 per share. | 15 May 2024 | 1,100 | 11,308 (0%) | 0% | 237.5 | 261,206 | Common Stock |
| Roland Goette | EVP and President EMEA | Sale of securities on an exchange or to another person at price $ 236.99 per share. | 15 May 2024 | 1,400 | 12,408 (0%) | 0% | 237.0 | 331,786 | Common Stock |
| Roland Goette | EVP and President EMEA | Sale of securities on an exchange or to another person at price $ 237.89 per share. | 13 May 2024 | 28 | 14,608 (0%) | 0% | 237.9 | 6,661 | Common Stock |
| Roland Goette | EVP and President EMEA | Sale of securities on an exchange or to another person at price $ 237.14 per share. | 13 May 2024 | 1,572 | 14,636 (0%) | 0% | 237.1 | 372,784 | Common Stock |
| Roland Goette | EVP and President EMEA | Sale of securities on an exchange or to another person at price $ 236.28 per share. | 13 May 2024 | 1,700 | 16,208 (0%) | 0% | 236.3 | 401,676 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 129 | 9,954 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 129 | 1,162 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Michael Garrison | EVP & President Medical | Sale of securities on an exchange or to another person at price $ 232.81 per share. | 30 Apr 2024 | 1,715 | 5,381 (0%) | 0% | 232.8 | 399,269 | Common Stock |
| Shana Carol Neal | EVP and Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Apr 2024 | 1,921 | 16,389 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | SVP,Controller&Chief Acct Off | Sale of securities on an exchange or to another person at price $ 238.29 per share. | 15 Mar 2024 | 282 | 2,276 (0%) | 0% | 238.3 | 67,198 | Common Stock |
| Thomas Spoerel | SVP,Controller&Chief Acct Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2024 | 36 | 2,558 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President NA & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2024 | 282 | 9,320 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2024 | 178 | 7,096 (0%) | 0% | 0 | Common Stock | |
| Carrie Byington L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 126 | 1,029 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Jones Ian Montague Christopher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 126 | 9,787 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 230 | 9,891 | - | - | Rights to Common Stock UnderBD Deferred Compensation Plan | |
| Jeffrey Henderson W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 5,568 (0%) | 0% | 0 | Common Stock | |
| L. Bertram Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 35,197 (0%) | 0% | 0 | Common Stock | |
| Timothy Ring M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 56,890 (0%) | 0% | 0 | Common Stock | |
| Jones Ian Montague Christopher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 21,405 (0%) | 0% | 0 | Common Stock | |
| William M. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 2,512 (0%) | 0% | 0 | Common Stock | |
| Catherine Burzik M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 13,242 (0%) | 0% | 0 | Common Stock | |
| R. Andrew Eckert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 8,124 (0%) | 0% | 0 | Common Stock | |
| Byington L. Carrie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 2,855 (0%) | 0% | 0 | Common Stock | |
| Waldstreicher Joanne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 1,323 (0%) | 0% | 0 | Common Stock | |
| M. Fraser-Liggett Claire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 22,696 (0%) | 0% | 0 | Common Stock | |
| David Shan | EVP and Chief ISC Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jan 2024 | 44 | 5,693 (0%) | 0% | 0 | Common Stock | |
| Garrison Michael | EVP & President Medical | Sale of securities on an exchange or to another person at price $ 232.46 per share. | 11 Dec 2023 | 1,239 | 7,274 (0%) | 0% | 232.5 | 288,018 | Common Stock |
| Richard Byrd | EVP & President Interventional | Sale of securities on an exchange or to another person at price $ 238.47 per share. | 28 Nov 2023 | 2,156 | 4,120 (0%) | 0% | 238.5 | 514,141 | Common Stock |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 32,296 | 91,385 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 11,429 | 59,089 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 19,574 | 71,811 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 63,335 | 63,335 | - | - | Stock Appreciation Rights | |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 7,520 | 70,855 | - | - | Rights to Common Stock Under Deferred Compensation Plan | |
| Roland Goette | EVP and President EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 3,225 | 3,225 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 582 | 15,995 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 2,608 | 18,603 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 213 | 18,390 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 258 | 18,310 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 1,659 | 18,568 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 9,190 | 9,190 | - | - | Stock Appreciation Rights | |
| Thomas Spoerel | SVPController & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 2,764 | 2,674 | - | - | Stock Appreciation Rights | |
| Thomas Spoerel | SVPController & Chief Acct Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 365 | 2,594 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | SVPController & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 757 | 2,959 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | SVPController & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 375 | 2,202 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President NA & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 3,113 | 11,256 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President NA & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 1,654 | 9,602 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President NA & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 5,298 | 5,298 | - | - | Stock Appreciation Rights | |
| Antoine C. Ezell | EVP, President NA & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 956 | 8,143 (0%) | 0% | 0 | Common Stock | |
| David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 3,024 | 12,237 | - | - | Rights to Common Stock Under Deferred Compensation Plan | |
| David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 1,663 | 5,862 (0%) | 0% | 0 | Common Stock | |
| David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 9,213 | 9,213 | - | - | Stock Appreciation Rights | |
| Christopher DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 18,425 | 18,425 | - | - | Stock Appreciation Rights | |
| Christopher DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 3,325 | 14,324 (0%) | 0% | 0 | Common Stock | |
| Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 812 | 13,512 (0%) | 0% | 0 | Common Stock | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 252 | 1,881 (0%) | 0% | 0 | Common Stock | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 64 | 1,817 (0%) | 0% | 0 | Common Stock | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 2,764 | 2,764 | - | - | Stock Appreciation Rights | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 499 | 1,629 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 1,646 | 8,513 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 3,131 | 10,159 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 10,364 | 10,364 | - | - | Stock Appreciation Rights | |
| Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 1,871 | 7,028 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 2,886 | 7,785 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 1,455 | 4,899 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 1,509 | 6,276 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 8,061 | 8,061 | - | - | Stock Appreciation Rights | |
| David Shan | EVP and Chief ISC Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 832 | 4,310 (0%) | 0% | 0 | Common Stock | |
| David Shan | EVP and Chief ISC Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 1,576 | 5,886 (0%) | 0% | 0 | Common Stock | |
| David Shan | EVP and Chief ISC Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 149 | 5,737 (0%) | 0% | 0 | Common Stock | |
| David Shan | EVP and Chief ISC Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 4,607 | 4,607 | - | - | Stock Appreciation Rights | |
| Michelle Quinn | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 1,206 | 4,486 (0%) | 0% | 0 | Common Stock | |
| Michelle Quinn | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 909 | 5,395 (0%) | 0% | 0 | Common Stock | |
| Michelle Quinn | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2023 | 440 | 4,955 (0%) | 0% | 0 | Common Stock | |
| Michelle Quinn | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2023 | 6,679 | 6,679 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 107.12 per share. | 16 Nov 2023 | 3,544 | 17,164 (0%) | 0% | 107.1 | 379,633 | Common Stock |
| Roland Goette | EVP and President, EMEA | Sale or transfer of securities back to the company at price $ 235.07 per share. | 16 Nov 2023 | 1,751 | 15,413 (0%) | 0% | 235.1 | 411,608 | Common Stock |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 3,544 | 0 | - | - | Stock Appreciation Rights | |
| Goette Roland | EVP and President, EMEA | Sale or transfer of securities back to the company at price $ 235.07 per share. | 16 Nov 2023 | 2,233 | 14,931 (0%) | 0% | 235.1 | 524,911 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2023 | 118 | 9,624 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2023 | 118 | 910 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Sep 2023 | 601 | 10,999 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Sale of securities on an exchange or to another person at price $ 274.48 per share. | 05 Sep 2023 | 459 | 3,444 (0%) | 0% | 274.5 | 125,986 | Common Stock |
| Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2023 | 353 | 11,600 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2023 | 216 | 3,903 (0%) | 0% | 0 | Common Stock | |
| Claire M. Fraser-Liggett | Director | Sale of securities on an exchange or to another person at price $ 281.66 per share. | 28 Aug 2023 | 848 | 21,608 (0%) | 0% | 281.7 | 238,848 | Common Stock |
| David Hickey | EVP & President, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 3,883 | 0 | - | - | Stock Appreciation Rights | |
| David Hickey | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 277.85 per share. | 11 Aug 2023 | 2,974 | 4,199 (0%) | 0% | 277.9 | 826,326 | Common Stock |
| David Hickey | EVP & President, Life Sciences | Sale or transfer of securities back to the company at price $ 277.85 per share. | 11 Aug 2023 | 1,857 | 7,173 (0%) | 0% | 277.8 | 515,967 | Common Stock |
| David Hickey | EVP & President, Life Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.54 per share. | 11 Aug 2023 | 3,883 | 9,030 (0%) | 0% | 132.5 | 514,653 | Common Stock |
| Michael Garrison | EVP & President Medical | Sale of securities on an exchange or to another person at price $ 277.13 per share. | 08 Aug 2023 | 1,300 | 5,157 (0%) | 0% | 277.1 | 360,269 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 108 | 9,441 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 108 | 785 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Joanne Waldstreicher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 419 | 419 (0%) | 0% | 0 | Common Stock | |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 118 | 9,270 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 118 | 671 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Michelle Quinn | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 May 2023 | 99 | 3,280 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 8,229 | 16,909 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Apr 2023 | 731 | 8,680 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President NA & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Mar 2023 | 650 | 7,187 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | SVP,Controller&Chief Acct Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2023 | 35 | 1,874 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President NA & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2023 | 418 | 7,837 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2023 | 193 | 6,457 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Sale of securities on an exchange or to another person at price $ 248.60 per share. | 03 Feb 2023 | 1,421 | 4,119 (0%) | 0% | 248.6 | 353,261 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 205 | 9,086 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 106 | 548 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Bertram L. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 33,779 (0%) | 0% | 0 | Common Stock | |
| Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 13,425 (0%) | 0% | 0 | Common Stock | |
| Claire M. Fraser-Liggett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 22,311 (0%) | 0% | 0 | Common Stock | |
| Marshall O. Larsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 28,919 (0%) | 0% | 0 | Common Stock | |
| Timothy M. Ring | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 78,830 (0%) | 0% | 0 | Common Stock | |
| William M. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 1,586 (0%) | 0% | 0 | Common Stock | |
| Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 4,653 (0%) | 0% | 0 | Common Stock | |
| R. Andrew Eckert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 6,992 (0%) | 0% | 0 | Common Stock | |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 29,171 (0%) | 0% | 0 | Common Stock | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 1,924 (0%) | 0% | 0 | Common Stock | |
| Ian Montague Christopher Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 20,198 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP and General Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Dec 2022 | 19 | 9,251 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP and General Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2022 | 40 | 9,270 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 3,334 | 9,262 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 12,484 | 12,484 | - | - | Stock Appreciation Rights | |
| Samrat S. Khichi | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 1,908 | 9,310 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,956 | 11,218 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 17,678 | 58,133 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 11,577 | 40,455 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,927 | 1,927 | - | - | Rights to Common Stock Under Deferred Compensation Plan | |
| Thomas E. Polen | Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 69,966 | 69,966 | - | - | Stock Appreciation Rights | |
| Thomas E. Polen | Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 10,473 | 47,660 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 99 | 13,620 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 3,842 | 3,842 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 636 | 12,536 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,183 | 13,719 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,812 | 9,411 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 10,948 | 10,948 | - | - | Stock Appreciation Rights | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 294 | 2,141 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 375 | 1,847 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 232 | 1,909 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 3,019 | 3,019 | - | - | Stock Appreciation Rights | |
| Antoine C. Ezell | EVP, President NA & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 115 | 8,255 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President NA & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 6,311 | 6,311 | - | - | Stock Appreciation Rights | |
| Antoine C. Ezell | EVP, President NA & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,045 | 8,370 (0%) | 0% | 0 | Common Stock | |
| David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,125 | 12,100 | - | - | Rights to Common Stock Under Deferred Compensation Plan | |
| David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,816 | 5,147 (0%) | 0% | 0 | Common Stock | |
| David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 10,975 | 10,975 | - | - | Stock Appreciation Rights | |
| Christopher DelOrefice | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 269 | 11,953 (0%) | 0% | 0 | Common Stock | |
| Christopher DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 18,658 | 18,658 | - | - | Stock Appreciation Rights | |
| Christopher DelOrefice | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 3,087 | 12,222 (0%) | 0% | 0 | Common Stock | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 364 | 1,078 (0%) | 0% | 0 | Common Stock | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 46 | 1,130 (0%) | 0% | 0 | Common Stock | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 2,195 | 2,195 | - | - | Stock Appreciation Rights | |
| Pavan Kumar Mocherla | EVP & President Greater Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 98 | 1,176 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President Medical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 617 | 6,650 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 9,466 | 9,466 | - | - | Stock Appreciation Rights | |
| Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,223 | 7,267 (0%) | 0% | 0 | Common Stock | |
| Michael Garrison | EVP & President Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,567 | 6,044 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,226 | 4,976 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 1,275 | 6,251 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2022 | 711 | 5,540 (0%) | 0% | 0 | Common Stock | |
| Richard Byrd | EVP & President Interventional | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2022 | 7,409 | 7,409 | - | - | Stock Appreciation Rights | |
| Shana Carol Neal | EVP and Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 18 Nov 2022 | 31 | 16,831 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 111 | 337 | - | - | Rights to Common Stock Under Deferred Compensation Plan | |
| Shana Carol Neal | EVP and Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 110 | 448 | - | - | Rights to Common Stock Under Deferred Compensation Plan | |
| Shana Carol Neal | EVP and Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 110 | 558 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Shana Carol Neal | EVP and Chief People Officer | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 18 Nov 2022 | 788 | 16,201 (0%) | 0% | 235 | 185,180 | Common Stock |
| Shana Carol Neal | EVP and Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 18 Nov 2022 | 32 | 16,989 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 111 | 17,021 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 18 Nov 2022 | 31 | 16,910 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 110 | 16,941 (0%) | 0% | 0 | Common Stock | |
| Shana Carol Neal | EVP and Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2022 | 110 | 16,862 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President, EMEA | Sale or transfer of securities back to the company at price $ 222.08 per share. | 16 Nov 2022 | 2,996 | 11,900 (0%) | 0% | 222.1 | 665,352 | Common Stock |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2022 | 4,617 | 0 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.94 per share. | 16 Nov 2022 | 4,617 | 14,896 (0%) | 0% | 74.9 | 345,998 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2022 | 113 | 8,881 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2022 | 113 | 440 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Christopher DelOrefice | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Sep 2022 | 506 | 9,135 (0%) | 0% | 0 | Common Stock | |
| Christopher DelOrefice | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,674 | 9,641 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Director, Chairman, CEO and President | Sale or transfer of securities back to the company at price $ 265.13 per share. | 15 Aug 2022 | 5,500 | 38,378 (0%) | 0% | 265.1 | 1,458,215 | Common Stock |
| Thomas E. Polen | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 167.91 per share. | 15 Aug 2022 | 15,000 | 43,878 (0%) | 0% | 167.9 | 2,518,650 | Common Stock |
| Thomas E. Polen | Director, Chairman, CEO and President | Sale of securities on an exchange or to another person at price $ 265.13 per share. | 15 Aug 2022 | 9,500 | 28,878 (0%) | 0% | 265.1 | 2,518,735 | Common Stock |
| Thomas E. Polen | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 15,000 | 15,184 | - | - | Stock Appreciation Rights | |
| David Hickey | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 265.00 per share. | 15 Aug 2022 | 475 | 3,331 (0%) | 0% | 265 | 125,875 | Common Stock |
| Samrat S. Khichi | EVP and General Counsel | Sale or transfer of securities back to the company at price $ 260.44 per share. | 09 Aug 2022 | 5,194 | 13,223 (0%) | 0% | 260.4 | 1,352,725 | Common Stock |
| Samrat S. Khichi | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 108.25 per share. | 09 Aug 2022 | 12,489 | 18,417 (0%) | 0% | 108.2 | 1,351,934 | Common Stock |
| Samrat S. Khichi | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 260.44 per share. | 09 Aug 2022 | 9,185 | 5,928 (0%) | 0% | 260.4 | 2,392,141 | Common Stock |
| Samrat S. Khichi | EVP and General Counsel | Sale or transfer of securities back to the company at price $ 260.44 per share. | 09 Aug 2022 | 5,141 | 15,113 (0%) | 0% | 260.4 | 1,338,922 | Common Stock |
| Samrat S. Khichi | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.49 per share. | 09 Aug 2022 | 14,326 | 20,254 (0%) | 0% | 93.5 | 1,339,338 | Common Stock |
| Samrat S. Khichi | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 12,489 | 0 | - | - | Stock Appreciation Rights | |
| Samrat S. Khichi | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 14,326 | 0 | - | - | Stock Appreciation Rights | |
| Samrat S. Khichi | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 260.44 per share. | 09 Aug 2022 | 7,295 | 5,928 (0%) | 0% | 260.4 | 1,899,910 | Common Stock |
| Thomas E. Polen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2022 | 3,825 | 0 | - | - | Stock Appreciation Rights | |
| Thomas E. Polen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 147.68 per share. | 09 Aug 2022 | 3,825 | 32,703 (0%) | 0% | 147.7 | 564,876 | Common Stock |
| Thomas E. Polen | Executive Vice President | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 09 Aug 2022 | 1,652 | 28,878 (0%) | 0% | 260 | 429,520 | Common Stock |
| Thomas E. Polen | Executive Vice President | Sale or transfer of securities back to the company at price $ 260.00 per share. | 09 Aug 2022 | 2,173 | 30,530 (0%) | 0% | 260 | 564,980 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 109 | 8,768 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 109 | 327 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Rishi Grover | EVP and Chief ISC Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2022 | 9,340 | 9,439 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 47 | 1,827 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 414 | 1,472 (0%) | 0% | 0 | Common Stock | |
| James Lim | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 3,280 | 23,941 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Sale or transfer of securities back to the company at price $ 260.00 per share. | 07 Jun 2022 | 583 | 1,487 (0%) | 0% | 260 | 151,580 | Common Stock |
| Thomas Spoerel | VP Controller & Chief Acct Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 147.68 per share. | 07 Jun 2022 | 1,026 | 2,070 (0%) | 0% | 147.7 | 151,520 | Common Stock |
| Thomas Spoerel | VP Controller & Chief Acct Off | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 07 Jun 2022 | 443 | 1,058 (0%) | 0% | 260 | 115,180 | Common Stock |
| Thomas Spoerel | VP Controller & Chief Acct Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 1,026 | 0 | - | - | Stock Appreciation Rights | |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 107 | 8,659 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| David Hickey | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 256.00 per share. | 06 May 2022 | 475 | 3,806 (0%) | 0% | 256 | 121,600 | Common Stock |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 107 | 215 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Shana Carol Neal | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2022 | 7,525 | 7,599 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2022 | 35 | 1,044 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President, NA & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2022 | 276 | 7,935 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President, NA & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2022 | 610 | 7,325 (0%) | 0% | 0 | Common Stock | |
| William M. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 714 | 714 (0%) | 0% | 0 | Common Stock | |
| Betty D. Larson | EVP HR & CHRO | Sale or transfer of securities back to the company at price $ 271.90 per share. | 25 Feb 2022 | 1,463 | 8,022 (0%) | 0% | 271.9 | 397,790 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 110.04 per share. | 25 Feb 2022 | 3,613 | 9,485 (0%) | 0% | 110.0 | 397,575 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale or transfer of securities back to the company at price $ 271.90 per share. | 25 Feb 2022 | 4,935 | 10,314 (0%) | 0% | 271.9 | 1,341,827 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,684 | 11,052 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 1,244 | 2,490 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 4,630 | 4,630 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 6,789 | 2,265 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 10,245 | 0 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 9,377 | 0 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 7,076 | 0 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,613 | 0 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Sale of securities on an exchange or to another person at price $ 271.90 per share. | 25 Feb 2022 | 601 | 5,872 (0%) | 0% | 271.9 | 163,412 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale or transfer of securities back to the company at price $ 271.90 per share. | 25 Feb 2022 | 3,083 | 6,473 (0%) | 0% | 271.9 | 838,268 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 227.47 per share. | 25 Feb 2022 | 3,684 | 9,556 (0%) | 0% | 227.5 | 837,999 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale of securities on an exchange or to another person at price $ 271.90 per share. | 25 Feb 2022 | 203 | 5,872 (0%) | 0% | 271.9 | 55,196 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale or transfer of securities back to the company at price $ 271.90 per share. | 25 Feb 2022 | 1,041 | 6,075 (0%) | 0% | 271.9 | 283,048 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 227.47 per share. | 25 Feb 2022 | 1,244 | 7,116 (0%) | 0% | 227.5 | 282,973 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale of securities on an exchange or to another person at price $ 271.90 per share. | 25 Feb 2022 | 284 | 5,872 (0%) | 0% | 271.9 | 77,220 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale or transfer of securities back to the company at price $ 271.90 per share. | 25 Feb 2022 | 4,346 | 6,156 (0%) | 0% | 271.9 | 1,181,677 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 255.22 per share. | 25 Feb 2022 | 4,630 | 10,502 (0%) | 0% | 255.2 | 1,181,669 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale of securities on an exchange or to another person at price $ 271.90 per share. | 25 Feb 2022 | 744 | 5,872 (0%) | 0% | 271.9 | 202,294 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale or transfer of securities back to the company at price $ 271.90 per share. | 25 Feb 2022 | 6,045 | 6,616 (0%) | 0% | 271.9 | 1,643,636 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 242.10 per share. | 25 Feb 2022 | 6,789 | 12,661 (0%) | 0% | 242.1 | 1,643,617 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale of securities on an exchange or to another person at price $ 271.90 per share. | 25 Feb 2022 | 2,036 | 5,872 (0%) | 0% | 271.9 | 553,588 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale or transfer of securities back to the company at price $ 271.90 per share. | 25 Feb 2022 | 8,209 | 7,908 (0%) | 0% | 271.9 | 2,232,027 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 217.84 per share. | 25 Feb 2022 | 10,245 | 16,117 (0%) | 0% | 217.8 | 2,231,771 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale of securities on an exchange or to another person at price $ 271.90 per share. | 25 Feb 2022 | 4,442 | 5,872 (0%) | 0% | 271.9 | 1,207,780 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 143.07 per share. | 25 Feb 2022 | 9,377 | 15,249 (0%) | 0% | 143.1 | 1,341,567 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale of securities on an exchange or to another person at price $ 271.90 per share. | 25 Feb 2022 | 3,914 | 5,872 (0%) | 0% | 271.9 | 1,064,217 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale or transfer of securities back to the company at price $ 271.90 per share. | 25 Feb 2022 | 3,162 | 9,786 (0%) | 0% | 271.9 | 859,748 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 121.49 per share. | 25 Feb 2022 | 7,076 | 12,948 (0%) | 0% | 121.5 | 859,663 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale of securities on an exchange or to another person at price $ 271.90 per share. | 25 Feb 2022 | 2,150 | 5,872 (0%) | 0% | 271.9 | 584,585 | Common Stock |
| Simon D. Campion | EVP and Segment President | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2022 | 50 | 10,319 (0%) | 0% | 0 | Common Stock | |
| Claire M. Fraser-Liggett | Director | Sale of securities on an exchange or to another person at price $ 271.70 per share. | 08 Feb 2022 | 841 | 21,556 (0%) | 0% | 271.7 | 228,500 | Common Stock |
| Samrat S. Khichi | EVP and General Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2022 | 375 | 5,928 (0%) | 0% | 0 | Common Stock | |
| Alexandre Conroy | EVP of Integrated Supply Chain | Sale or transfer of securities back to the company at price $ 270.16 per share. | 03 Feb 2022 | 6,377 | 27,670 (0%) | 0% | 270.2 | 1,722,810 | Common Stock |
| Alexandre Conroy | EVP of Integrated Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 134.73 per share. | 03 Feb 2022 | 12,787 | 34,047 (0%) | 0% | 134.7 | 1,722,793 | Common Stock |
| Alexandre Conroy | EVP of Integrated Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 12,787 | 0 | - | - | Stock Appreciation Rights | |
| Alexandre Conroy | EVP of Integrated Supply Chain | Sale of securities on an exchange or to another person at price $ 270.16 per share. | 03 Feb 2022 | 6,410 | 21,260 (0%) | 0% | 270.2 | 1,731,726 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 203 | 8,325 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 105 | 105 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Simon D. Campion | EVP and Segment President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Jan 2022 | 190 | 10,369 (0%) | 0% | 0 | Common Stock | |
| Bertram L. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 31,860 (0%) | 0% | 0 | Common Stock | |
| Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 12,499 (0%) | 0% | 0 | Common Stock | |
| David F. Melcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 6,180 (0%) | 0% | 0 | Common Stock | |
| Claire M. Fraser-Liggett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 22,397 (0%) | 0% | 0 | Common Stock | |
| Marshall O. Larsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 23,806 (0%) | 0% | 0 | Common Stock | |
| Timothy M. Ring | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 77,816 (0%) | 0% | 0 | Common Stock | |
| Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 3,777 (0%) | 0% | 0 | Common Stock | |
| R. Andrew Eckert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 6,216 (0%) | 0% | 0 | Common Stock | |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 18,701 (0%) | 0% | 0 | Common Stock | |
| Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 9,982 (0%) | 0% | 0 | Common Stock | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 1,042 (0%) | 0% | 0 | Common Stock | |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2021 | 893 | 0 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Sale of securities on an exchange or to another person at price $ 255.00 per share. | 16 Dec 2021 | 552 | 8,661 (0%) | 0% | 255 | 140,760 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale of securities on an exchange or to another person at price $ 255.00 per share. | 16 Dec 2021 | 2,789 | 5,872 (0%) | 0% | 255 | 711,195 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Sale or transfer of securities back to the company at price $ 255.00 per share. | 16 Dec 2021 | 341 | 9,213 (0%) | 0% | 255 | 86,955 | Common Stock |
| Betty D. Larson | EVP HR & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 97.14 per share. | 16 Dec 2021 | 893 | 9,554 (0%) | 0% | 97.1 | 86,746 | Common Stock |
| Thomas Spoerel | VP Controller & Chief Acct Off | Sale of securities on an exchange or to another person at price $ 250.00 per share. | 07 Dec 2021 | 233 | 1,079 (0%) | 0% | 250 | 58,250 | Common Stock |
| Christopher R. Reidy | CFO and EVP of Administration | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2021 | 1,132 | 28,579 (0%) | 0% | 0 | Common Stock | |
| Christopher R. Reidy | CFO and EVP of Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 2,945 | 31,524 (0%) | 0% | 0 | Common Stock | |
| Christopher R. Reidy | CFO and EVP of Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 2,053 | 29,711 (0%) | 0% | 0 | Common Stock | |
| Alexandre Conroy | EVP of Integrated Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2021 | 863 | 19,938 (0%) | 0% | 0 | Common Stock | |
| Alexandre Conroy | EVP of Integrated Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 9,469 | 9,469 | - | - | Stock Appreciation Rights | |
| Alexandre Conroy | EVP of Integrated Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,325 | 21,260 (0%) | 0% | 0 | Common Stock | |
| Alexandre Conroy | EVP of Integrated Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,210 | 20,798 (0%) | 0% | 0 | Common Stock | |
| James Lim | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 893 | 20,661 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,914 | 6,303 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 13,678 | 13,678 | - | - | Stock Appreciation Rights | |
| Samrat S. Khichi | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 990 | 5,070 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2021 | 681 | 4,389 (0%) | 0% | 0 | Common Stock | |
| Betty D. Larson | EVP HR & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,813 | 8,661 (0%) | 0% | 0 | Common Stock | |
| Betty D. Larson | EVP HR & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2021 | 580 | 6,848 (0%) | 0% | 0 | Common Stock | |
| Betty D. Larson | EVP HR & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 12,956 | 12,956 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 843 | 7,428 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 10,583 | 28,878 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 75,632 | 75,632 | - | - | Stock Appreciation Rights | |
| Thomas E. Polen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2021 | 1,913 | 18,295 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 2,786 | 20,208 (0%) | 0% | 0 | Common Stock | |
| Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 2,116 | 11,662 (0%) | 0% | 0 | Common Stock | |
| Alberto Ribo Mas | EVP and Pres, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2021 | 798 | 9,546 (0%) | 0% | 0 | Common Stock | |
| Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,686 | 10,344 (0%) | 0% | 0 | Common Stock | |
| Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 15,121 | 15,121 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 625 | 10,279 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 4,464 | 4,464 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 312 | 9,685 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2021 | 31 | 9,654 (0%) | 0% | 0 | Common Stock | |
| Simon D. Campion | EVP and Segment President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2021 | 650 | 8,811 (0%) | 0% | 0 | Common Stock | |
| Simon D. Campion | EVP and Segment President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,748 | 10,559 (0%) | 0% | 0 | Common Stock | |
| Simon D. Campion | EVP and Segment President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 12,487 | 12,487 | - | - | Stock Appreciation Rights | |
| Simon D. Campion | EVP and Segment President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,027 | 9,461 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 287 | 1,312 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 2,726 | 2,726 | - | - | Stock Appreciation Rights | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2021 | 195 | 1,025 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 202 | 1,220 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President, NA & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 5,411 | 5,411 | - | - | Stock Appreciation Rights | |
| Antoine C. Ezell | EVP, President, NA & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 758 | 8,211 (0%) | 0% | 0 | Common Stock | |
| David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,511 | 5,366 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,473 | 5,059 (0%) | 0% | 0 | Common Stock | |
| David Hickey | EVP & President, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 10,522 | 10,522 | - | - | Stock Appreciation Rights | |
| Christopher DelOrefice | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 18,638 | 18,638 | - | - | Stock Appreciation Rights | |
| Christopher DelOrefice | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 2,608 | 6,967 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.11 per share. | 16 Nov 2021 | 1,914 | 9,373 (0%) | 0% | 244.1 | 467,227 | Common Stock |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 3,055 | 0 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.12 per share. | 16 Nov 2021 | 3,055 | 11,287 (0%) | 0% | 72.1 | 220,327 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 112 | 8,093 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Carrie L. Byington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2021 | 221 | 221 (0%) | 0% | 0 | Common Stock | |
| Rebecca W. Rimel | Director | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 08 Sep 2021 | 500 | 10,618 (0%) | 0% | 260 | 130,000 | Common Stock |
| Thomas Spoerel | VP Controller & Chief Acct Off | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 08 Sep 2021 | 267 | 1,018 (0%) | 0% | 260 | 69,420 | Common Stock |
| David Hickey | EVP & President, Life Sciences | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 08 Sep 2021 | 500 | 3,586 (0%) | 0% | 260 | 130,000 | Common Stock |
| Christopher DelOrefice | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2021 | 4,359 | 4,359 (0%) | 0% | 0 | Common Stock | |
| David Hickey | EVP & President, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Sep 2021 | 268 | 4,086 (0%) | 0% | 0 | Common Stock | |
| Rebecca W. Rimel | Director | Sale of securities on an exchange or to another person at price $ 257.10 per share. | 03 Sep 2021 | 500 | 11,118 (0%) | 0% | 257.1 | 128,550 | Common Stock |
| James Lim | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 14,584 | 0 | - | - | Stock Appreciation Rights | |
| James Lim | Executive Vice President | Sale of securities on an exchange or to another person at price $ 257.44 per share. | 03 Sep 2021 | 6,956 | 19,768 (0%) | 0% | 257.4 | 1,790,753 | Common Stock |
| James Lim | Executive Vice President | Sale or transfer of securities back to the company at price $ 257.44 per share. | 03 Sep 2021 | 7,628 | 26,724 (0%) | 0% | 257.4 | 1,963,752 | Common Stock |
| James Lim | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 134.73 per share. | 03 Sep 2021 | 14,584 | 34,352 (0%) | 0% | 134.7 | 1,964,902 | Common Stock |
| Rebecca W. Rimel | Director | Sale of securities on an exchange or to another person at price $ 254.00 per share. | 02 Sep 2021 | 244 | 11,618 (0%) | 0% | 254 | 61,976 | Common Stock |
| Rebecca W. Rimel | Director | Sale of securities on an exchange or to another person at price $ 252.00 per share. | 30 Aug 2021 | 207 | 11,862 (0%) | 0% | 252 | 52,164 | Common Stock |
| Claire M. Fraser-Liggett | Director | Sale of securities on an exchange or to another person at price $ 251.58 per share. | 18 Aug 2021 | 387 | 20,220 (0%) | 0% | 251.6 | 97,361 | Common Stock |
| Rebecca W. Rimel | Director | Sale of securities on an exchange or to another person at price $ 252.00 per share. | 17 Aug 2021 | 207 | 12,069 (0%) | 0% | 252 | 52,164 | Common Stock |
| Thomas Spoerel | VP Controller & Chief Acct Off | Sale of securities on an exchange or to another person at price $ 242.30 per share. | 06 Aug 2021 | 266 | 1,285 (0%) | 0% | 242.3 | 64,452 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 104 | 7,927 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| James Lim | Executive Vice President | Sale of securities on an exchange or to another person at price $ 241.68 per share. | 28 May 2021 | 3,429 | 801 (0%) | 0% | 241.7 | 828,721 | Common Stock |
| Claire M. Fraser-Liggett | Director | Sale of securities on an exchange or to another person at price $ 241.36 per share. | 27 May 2021 | 390 | 20,607 (0%) | 0% | 241.4 | 94,130 | Common Stock |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 107 | 7,823 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Antoine C. Ezell | EVP, President, NA & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Mar 2021 | 505 | 4,636 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 302 | 1,551 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President, NA & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,817 | 7,453 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Feb 2021 | 1,616 | 4,080 (0%) | 0% | 0 | Common Stock | |
| Betty D. Larson | EVP HR & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Feb 2021 | 760 | 6,585 (0%) | 0% | 0 | Common Stock | |
| Simon D. Campion | EVP and Segment President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Feb 2021 | 747 | 8,434 (0%) | 0% | 0 | Common Stock | |
| Bertram L. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 198 | 16,138 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 198 | 7,690 | - | - | Rights to Common Stock Under 1996 Directors Deferral Plan | |
| Simon D. Campion | EVP and Segment President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Jan 2021 | 198 | 9,181 (0%) | 0% | 0 | Common Stock | |
| Bertram L. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 30,515 (0%) | 0% | 0 | Common Stock | |
| Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 11,661 (0%) | 0% | 0 | Common Stock | |
| David F. Melcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 5,257 (0%) | 0% | 0 | Common Stock | |
| Claire M. Fraser-Liggett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 20,997 (0%) | 0% | 0 | Common Stock | |
| Marshall O. Larsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 22,986 (0%) | 0% | 0 | Common Stock | |
| Rebecca W. Rimel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 12,153 (0%) | 0% | 0 | Common Stock | |
| Timothy M. Ring | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 76,919 (0%) | 0% | 0 | Common Stock | |
| Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 2,918 (0%) | 0% | 0 | Common Stock | |
| R. Andrew Eckert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 5,384 (0%) | 0% | 0 | Common Stock | |
| Christopher Ian Montague Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 17,548 (0%) | 0% | 0 | Common Stock | |
| Claire Pomeroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 8,956 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2021 | 1,295 | 6,365 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2021 | 669 | 5,696 (0%) | 0% | 0 | Common Stock | |
| Betty D. Larson | EVP HR & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2021 | 679 | 7,345 (0%) | 0% | 0 | Common Stock | |
| Betty D. Larson | EVP HR & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2021 | 851 | 8,024 (0%) | 0% | 0 | Common Stock | |
| Simon D. Campion | EVP and Segment President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Jan 2021 | 195 | 9,379 (0%) | 0% | 0 | Common Stock | |
| Simon D. Campion | EVP and Segment President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2021 | 370 | 9,574 (0%) | 0% | 0 | Common Stock | |
| Vincent A. Forlenza | Director, Chairman of the Board | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2020 | 268 | 194,048 (0%) | 0% | 0 | Common Stock | |
| Simon D. Campion | EVP and Segment President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Dec 2020 | 205 | 9,204 (0%) | 0% | 0 | Common Stock | |
| Simon D. Campion | EVP and Segment President | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Dec 2020 | 50 | 9,409 (0%) | 0% | 0 | Common Stock | |
| Christopher R. Reidy | CFO and EVP of Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 2,372 | 29,582 (0%) | 0% | 0 | Common Stock | |
| Christopher R. Reidy | CFO and EVP of Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 9,716 | 9,716 | - | - | Stock Appreciation Rights | |
| Christopher R. Reidy | CFO and EVP of Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 29,912 | 29,912 | - | - | Stock Appreciation Rights | |
| Christopher R. Reidy | CFO and EVP of Administration | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2020 | 1,924 | 27,658 (0%) | 0% | 0 | Common Stock | |
| Alexandre Conroy | EVP of Integrated Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2020 | 1,125 | 19,588 (0%) | 0% | 0 | Common Stock | |
| Alexandre Conroy | EVP of Integrated Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 5,422 | 5,422 | - | - | Stock Appreciation Rights | |
| Alexandre Conroy | EVP of Integrated Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 15,067 | 15,067 | - | - | Stock Appreciation Rights | |
| Alexandre Conroy | EVP of Integrated Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 1,253 | 20,713 (0%) | 0% | 0 | Common Stock | |
| James Lim | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 10,919 | 10,919 | - | - | Stock Appreciation Rights | |
| James Lim | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 3,745 | 3,745 | - | - | Stock Appreciation Rights | |
| James Lim | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 802 | 19,768 (0%) | 0% | 0 | Common Stock | |
| Samrat S. Khichi | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 14,984 | 14,984 | - | - | Stock Appreciation Rights | |
| Samrat S. Khichi | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 5,001 | 5,001 | - | - | Stock Appreciation Rights | |
| Samrat S. Khichi | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2020 | 192 | 5,070 (0%) | 0% | 0 | Common Stock | |
| Betty D. Larson | EVP HR & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2020 | 164 | 7,173 (0%) | 0% | 0 | Common Stock | |
| Betty D. Larson | EVP HR & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 3,734 | 3,734 | - | - | Stock Appreciation Rights | |
| Betty D. Larson | EVP HR & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 14,736 | 14,736 | - | - | Stock Appreciation Rights | |
| Thomas E. Polen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 2,657 | 19,774 (0%) | 0% | 0 | Common Stock | |
| Thomas E. Polen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 92,298 | 92,298 | - | - | Stock Appreciation Rights | |
| Thomas E. Polen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2020 | 2,352 | 17,422 (0%) | 0% | 0 | Common Stock | |
| Patrick Kaltenbach | EVP & Pres Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 621 | 621 | - | - | Rights to Common Stock Under BD Deferred Compensation Plan | |
| Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 5,893 | 5,893 | - | - | Stock Appreciation Rights | |
| Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 21,694 | 21,694 | - | - | Stock Appreciation Rights | |
| Alberto Ribo Mas | EVP and Pres, Life Sciences | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 949 | 9,330 (0%) | 0% | 0 | Common Stock | |
| Alberto Ribo Mas | EVP and Pres, Life Sciences | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2020 | 672 | 8,658 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 266 | 6,866 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President, EMEA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2020 | 36 | 6,830 (0%) | 0% | 0 | Common Stock | |
| Roland Goette | EVP and President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 6,044 | 6,044 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 1,279 | 1,279 | - | - | Stock Appreciation Rights | |
| Simon D. Campion | EVP and Segment President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2020 | 184 | 9,459 (0%) | 0% | 0 | Common Stock | |
| Simon D. Campion | EVP and Segment President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 16,023 | 16,023 | - | - | Stock Appreciation Rights | |
| Simon D. Campion | EVP and Segment President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 3,154 | 3,154 | - | - | Stock Appreciation Rights | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 2,319 | 2,319 | - | - | Stock Appreciation Rights | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 1,004 | 1,004 | - | - | Stock Appreciation Rights | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 238 | 1,249 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 26 Nov 2020 | 222 | 1,011 (0%) | 0% | 0 | Common Stock | |
| Thomas Spoerel | VP Controller & Chief Acct Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 257 | 1,233 (0%) | 0% | 0 | Common Stock | |
| Antoine C. Ezell | EVP, President, NA & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2020 | 7,215 | 7,215 | - | - | Stock Appreciation Rights | |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.64 per share. | 23 Nov 2020 | 3,485 | 10,085 (0%) | 0% | 76.6 | 267,090 | Common Stock |
| Roland Goette | EVP and President, EMEA | Sale or transfer of securities back to the company at price $ 230.10 per share. | 23 Nov 2020 | 1,161 | 8,924 (0%) | 0% | 230.1 | 267,146 | Common Stock |
| Roland Goette | EVP and President, EMEA | Sale of securities on an exchange or to another person at price $ 230.10 per share. | 23 Nov 2020 | 930 | 7,994 (0%) | 0% | 230.1 | 213,993 | Common Stock |
| Roland Goette | EVP and President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 3,485 | 0 | - | - | Stock Appreciation Rights | |
| Vincent A. Forlenza | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2020 | 7,969 | 201,396 (0%) | 0% | 0 | Common Stock | |
| Vincent A. Forlenza | Director, Chairman of the Board | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2020 | 462 | 193,427 (0%) | 0% | 0 | Common Stock | |
| Vincent A. Forlenza | Director, Chairman of the Board | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2020 | 104 | 193,889 (0%) | 0% | 0 | Common Stock | |
| Vincent A. Forlenza | Director, Chairman of the Board | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2020 | 7,507 | 193,993 (0%) | 0% | 0 | Common Stock |